TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Cooperative Groups Won’t Get Grants For Head & Neck Cancer, Must Compete For Contract Awards July 1, 1977
TCL Archive In Brief: SBA Writing Guidelines to Implement Act Giving 1.25 Percent Of R&D Budget To Small Business July 23, 1982
TCL Archive In Brief: St. Jude To Stay In Memphis; Katterhagens Move To Illinois; ACCC, Nixon In DC Next Week March 28, 1986
